Skip to content

301367.SZ

BMC Medical Co., Ltd.

SZSE · C 制造业 · CN

CNY 43.78
−4.31%
Ask drillr

Year over year

Reported trailing growth

Revenue
+31.3%
EBITDA
—
EBIT
+12.8%
EPS
+8.7%
Free cash flow
-15.5%
Operating cash flow
+2.8%

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
-6.4%
EBITDA
-14.3%
EBIT
-15.6%
Net income
-16.0%
EPS
-30.3%
Free cash flow
-34.7%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026